cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Seres Therapeutics Inc
6 own
23 watching
Current Price
$5.34
$-0.1
(-1.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
664.35M
52-Week High
52-Week High
9.49
52-Week Low
52-Week Low
2.5
Average Volume
Average Volume
1.32M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization664.35M
icon52-Week High9.49
icon52-Week Low2.5
iconAverage Volume1.32M
iconDividend Yield--
iconP/E Ratio--
What does the Seres Therapeutics Inc do?
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed Phase II clinical study to treat multiply recurrent Clostridium difficile infection (CDI). The company also develops SER-287 that is in Phase Ib clinical study in patients with mild-to-moderate ulcerative colitis; and SER-262, a synthetic microbiome therapeutic candidate, which is in Phase Ib study in patients with primary CDI. Its product candidates in pre-clinical development comprise SER-301, a synthetic Ecobiotic microbiome therapeutic candidate for the treatment of inflammatory bowel disease; and SER-155, an Ecobiotic microbiome therapeutic for the prevention of transplant-related mortality. Seres Therapeutics, Inc. has a strategic collaboration with Nestle Health Science and Memorial Sloan Kettering Cancer Center. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Seres Therapeutics Inc make?
News & Events about Seres Therapeutics Inc.
Business Wire
6days ago
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading microbiome therapeutics company, today announced that on February 1, 2023, the Compensation and Talent Committee of Seres board of directors granted inducement equity grants covering an aggregate of 48,750 shares of its...
Business Wire
27days ago
Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading microbiome therapeutics company, today announced that on January 11, 2023, the Compensation and Talent Committee of Seres board of directors granted inducement equity grants covering an aggregate of 13,500 shares of its...
Business Wire
3 months ago
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced the publication of Phase 3 clinical data in the Journal of the American Medical Association (JAMA), highlighting that the clinical benefits of investigational therapeutic SER-109 for preventing...
PR Newswire
3 months ago
Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform PR Newswire CAMBRIDGE, Mass., Oct. 17, 2022 Dr. Khrer has more than 25 years of RNA research and development experience, including pioneering novel...
PR Newswire
4 months ago
Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? PR Newswire NEW YORK, Sept. 23, 2022 NEW YORK...
Frequently Asked Questions
Frequently Asked Questions
What is Seres Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Seres Therapeutics Inc shares?
plus_minus_icon
How can I buy Seres Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Seres Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Seres Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Seres Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Seres Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Seres Therapeutics Inc?
plus_minus_icon
What percentage is Seres Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Seres Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.34
$-0.1
(-1.84%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Phibro Animal Health Corp
Phibro Animal Health Corp
$15.90
$-0.15 (-0.93 %)
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc.
$1.38
$0.02 (1.47 %)
Editas Medicine Inc.
Editas Medicine Inc.
$10.34
$-0.88 (-7.84 %)
Theravance Biopharma Inc
Theravance Biopharma Inc
$10.38
$-0.22 (-2.08 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Phibro Animal Health Corp
Phibro Animal Health Corp
$15.90
$-0.15 (-0.93 %)
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc.
$1.38
$0.02 (1.47 %)
Editas Medicine Inc.
Editas Medicine Inc.
$10.34
$-0.88 (-7.84 %)
Theravance Biopharma Inc
Theravance Biopharma Inc
$10.38
$-0.22 (-2.08 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00